Search Clinical Trials
By Condition
By Location (USA)
By Location (Other)
By Sponsor
Resources
Privacy Policy
About Us
Disclaimer
A Study of Motexafin Gadolinium for the Treatment of Chronic Lymphocytic Leukemia (CLL) Clinical Trials References presented on Clinical Trials Search is not intended to be a substitute for proven healthcare advice, trips or professional assistance by using a real medical. We aren't mDs. Always confer with your physician about A Study of Motexafin Gadolinium for the Treatment of Chronic Lymphocytic Leukemia (CLL) conditions. Clinical Trials Search.org is a website devoted to listing clinical research studies in human subjects. A Study of Motexafin Gadolinium for the Treatment of Chronic Lymphocytic Leukemia (CLL) Clinical research trials and A Study of Motexafin Gadolinium for the Treatment of Chronic Lymphocytic Leukemia (CLL) medical trials take place in hundreds of localities across the U.S.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually evaluate the effectualness of new does drugs. The purpose of the studies / projects is to solve specific human health questions. Clinical trials are a popular way for physicians, government agencies, and private sector companies to discover treatments for all sorts of conditions, such as A Study of Motexafin Gadolinium for the Treatment of Chronic Lymphocytic Leukemia (CLL). A Study of Motexafin Gadolinium for the Treatment of Chronic Lymphocytic Leukemia (CLL) Clinical Trials and other clinical trials permit volunteers to access healthcare treatment choices before they are available to the general public. Some times the subjects recieve professional assistance for without cost, and every now and again they are compensated for their time. Sometimes there is a cost for a A Study of Motexafin Gadolinium for the Treatment of Chronic Lymphocytic Leukemia (CLL) clinical trial. Subjects often receive the most expert healthcare possible for their A Study of Motexafin Gadolinium for the Treatment of Chronic Lymphocytic Leukemia (CLL) condition. Risks are a reality, nevertheless, and could include additional or frequent dr. calls, healthcare dangers (perhaps life-jeopardising), and/or the treatment being ineffective. Trials are federally governed with stern guidelines to protect clinical trials subjects.

Home > "A" Clinical Trials Conditions > A Study of Motexafin Gadolinium for the Treatment of Chronic Lymphocytic Leukemia (CLL)

A Study of Motexafin Gadolinium for the Treatment of Chronic Lymphocytic Leukemia (CLL)



A Study of Motexafin Gadolinium for the Treatment of Chronic Lymphocytic Leukemia (CLL)

For Condition: Leukemia,Leukemia, Lymphocytic, Chronic
Status: Recruiting
Sponsor(s): Pharmacyclics ,
Synopsis: The purpose of this study is to determine if the drug motexafin gadolinium will be an effective treatment for patients who have chronic lymphocytic leukemia (CLL) that has come back after treatment or that has stopped responding to treatment.
Details:
Eligibility:
Study Type:
  Interventional, Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Safety/Efficacy Study
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: Inclusion Criteria: - At least 18 years old - Refractory or relapsed CLL - ECOG performance status score of 0, 1, or 2 - Each patient must sign a study-specific informed consent form Exclusion Criteria: Laboratory values of: - Platelet count <30,000/uL - AST or ALT >2 x the upper limit of normal (ULN) - Total bilirubin >2 x ULN - Creatinine >2.0 mg/dL - Chemotherapy, radiation therapy, immunotherapy, systemic corticosteroids, or systemic biologic anticancer therapy within 21 days before beginning study treatment - Women who are pregnant or lactating
Total Enrollment: 27

Location and Contact Information:

Ohio State University Medical Center *Recruiting*
Columbus,  Ohio, 
United States
Recruiting  


Additional Information:
Study ID Numbers:
  PCYC-0216; 
Study Start Date: 
Record last reviewed: January 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00076401

Other Leukemia Studies:
1. Bone Marrow Transplant Studies for Safe and Effective Treatment of Leukemia

2. Captopril in Treating Patients Undergoing Bone Marrow or Stem Cell Transplantation

3. Peripheral Blood Lymphocyte Therapy to Prevent Lymphoproliferative Disorders Caused by Epstein-Barr Virus in Patients Who Have Undergone Transplantation

4. Irinotecan Plus Cyclosporine and Phenobarbital in Treating Patients With Solid Tumors or Lymphoma

5. Umbilical Cord Blood Transplantation in Treating Patients With High-Risk Hematologic Cancer

Related Studies:

Other Leukemia Clinical Trials
Other Ohio Clinical Trials
Other Columbus Clinical Trials

A Study of Motexafin Gadolinium for the Treatment of Chronic Lymphocytic Leukemia (CLL)

Modify your Search

  Other Leukemia Clinical Trials
  Other Ohio Clinical Trials
  Other Columbus Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103